Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Nautilus Biotechnology has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in January 2026.
Nautilus Biotechnology's investors include Franklin Templeton, Andreessen Horowitz, RA Capital Management, Madrona, Michael J. Fox Foundation.
Nautilus Biotechnology is headquartered in San Carlos, United States.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Nautilus Biotechnology is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nautilus Biotechnology — Funding & Investors." VCBacked, January 28, 2026, https://www.vcbacked.co/company/nautilus-biotechnology. Accessed July 19, 2026.
VCBacked. (2026). Nautilus Biotechnology — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/nautilus-biotechnology
{{cite web |title=Nautilus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/nautilus-biotechnology |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated